New drug approvals: May 2019
May has seen some interesting drugs approved by the US FDA, including treatments for type 2 diabetes, an autoimmune disorder and spinal muscular atrophy; check them out in this round-up of new therapies on the market.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>